Proteinuria
223 results
132 - 223
Statins for improving renal outcomes 
Interventions for chronic kidney disease in people with sickle cell disease- Immunosuppressive agents for treating IgA nephropathy
- Interventions for weight loss in people with chronic kidney disease who are overweight or obese
- Raynaud's phenomenon (RP) or white finger disease
- Urinalysis and bacterial culture
- Systemic lupus erythematosus (SLE)
ACE + ARB does not improve outcomes in pts with T2DM with impaired renal function (VA NEPHRON)- Diabetic kidney disease (diabetic nephropathy)
- Elevated blood pressure in pregnancy (gestational hypertension, pre-eclampsia)
- Antihypertensive treatment for kidney transplant recipients
- Steroids associated with increased risk of adverse outcomes in adults with IgA nephropathy
- Pentoxifylline for diabetic kidney disease
- Plasma volume expansion for treatment of pre‐eclampsia
- Anti‐angiogenic therapies for metastatic colorectal cancer
- Comprehensive treatment and follow-up of type 2 diabetes
- Secondary hypertension
- Astragalus (a traditional Chinese medicine) for treating chronic kidney disease: Cochrane systematic review
- JNC 8 report on prevention/evaluation/treatment of hypertension
- Chinese herbal medicines for treating pre‐eclampsia
- Protein restriction for children with chronic kidney disease
- Immunosuppressive therapy for IgA nephropathy in children
- Non‐immunosuppressive treatment for IgA nephropathy
- HMG CoA reductase inhibitors (statins) for kidney transplant recipients
- Hypertension: investigations, treatment initiation and non-pharmacological treatment
- HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
- Chronic diseases and pregnancy
- Protein restriction for diabetic kidney disease
- Epidemic nephropathy
- Better maternal outcomes with testing for placental growth factor when pre-eclampsia is suspected
- New ACR and EULAR criteria for diagnosing SLE
- Tight control no different from less-tight control of hypertension in pregnancy
- Heparin and related substances for preventing diabetic kidney disease: Cochrane systematic review
- Gold as an oral corticosteroid sparing agent in stable asthma
- Interventions for focal segmental glomerulosclerosis in adults
- Glomerulonephrites
- Interleukin 2 receptor antagonists for kidney transplant recipients
- BP target of 120 no better than 140 in T2DM (ACCORD)
- Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura
- Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
- ACE inhibitors and angiotensin II receptor blockers for diabetics with microalbuminuria
- Drug treatment for hypertension
- Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer
- Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non‐diabetic chronic kidney disease
- Drugs for treatment of very high blood pressure during pregnancy
- Blood pressure targets for hypertension in people with chronic renal disease
- Treatment approach for atrial fibrillation: rate control or rhythm control?
- Adder (Vipera berus) bite
- Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome
- Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
- Primary Sjögren's syndrome
- Uric acid lowering therapies for preventing or delaying the progression of chronic kidney disease
- Antihypertensive agents for preventing diabetic kidney disease
- Eosinophilia
- Antenatal clinics and specialist care: consultations, referrals, treatment guidelines
- Guided imagery for treating hypertension in pregnancy
- Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
- Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration: Cochrane systematic review
- Sirolimus and everolimus for primary immunosuppression in kidney transplant recipients
- Lipid‐lowering agents for nephrotic syndrome
- Antenatal clinics: care and examinations
- Statins for kidney transplant recipients
- Bacterial diseases in warm climates
- Oral fumaric acid esters for psoriasis
- Antioxidants for adults with chronic kidney disease
- Interventions for preventing bone disease in kidney transplant recipients
- Antiplatelet agents for chronic kidney disease
- Interventions for renal vasculitis in adults
- Glucose targets for preventing diabetic kidney disease and its progression
- Education programmes for people with chronic kidney disease and diabetes
- Calcium supplementation commencing before or early in pregnancy, for preventing hypertensive disorders of pregnancy
- Anti‐angiogenic therapy for high‐grade glioma
- Metformin for preventing the progression of chronic kidney disease
- ACE inhibitors and angiotensin receptor blockers for progression of non-diabetic renal disease
- Polycystic kidney disease
- Synbiotics, prebiotics and probiotics for people with chronic kidney disease
- Treatment for hepatitis C virus‐associated mixed cryoglobulinaemia
- Treatment of chronic renal failure